Sayantan Mitra

Sayantan is a protein engineer with a deep passion in helping discover and develop novel therapeutic treatments for cancer and autoimmune diseases. He has over 16 years of experience in peptide chemistry, protein and antibody engineering, therapeutic antibody discovery, cytokine engineering and cell therapy. He has been a key contributor to several different modalities in clinical development such as monoclonal antibodies, conditionally active bispecific antibodies and engineered cytokines. Prior to joining BigHat, Sayantan led the Protein Sciences team at Metagenomi developing innovative ex-vivo cell therapies. Sayantan holds a PhD in Chemical Biology from the University of Southern California and conducted Postdoctoral Research in Cell Biology at Sanford Burnham Prebys Medical Discovery Institute.